共 50 条
- [1] FXR activation in breast cancer: Friend or foe? [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1250 - 1251
- [4] Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe? [J]. Current Oncology Reports, 2012, 14 : 1 - 11
- [6] Anthracyclines in the treatment of early breast cancer friend or foe? [J]. BREAST, 2022, 65 : 67 - 76
- [7] Microenvironment and endocrine resistance in breast cancer: Friend or foe? [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (06): : 207 - 211